Health is a prosperous state of body, soul, and social that allows everyone to live socially and economically productive. Health care is an effort to overcome and prevent health problems that require examination, treatment and care including pregnancy and childbirth. On this occasion I will explain the health project of Digipharms. Which supports the Supply in Health Sector. Digipharms Be a pioneer in the delivery of sustainable health services and patient empowerment in the healthcare industry.

Digipharms is one of the projects that work together in equality, health and patient care in the health field. Which has the goal of accelerating the handling of welfare and patient guarantees in the form of a value-based approach.
Market potential
The use and reliance on RWE is rising and can have vast effect in assisting medical research, trial execution and determination making in healthcare. There is a clean desire for the provision of timely and with out difficulty available RWD to tell industry, coverage makers, services and payers of product performance. Regulatory our bodies and HTA businesses are absolutely supportive of its use. Pharmaceutical companies and well being insurers steadily acquire aggregates of RWD or sponsor RWE studies for monumental quantities of money, typically collecting guide it’s now not required or useful resulting in a waste of resources. The call for for powerful and well timed RWD shall basically growth as payers and regulatory businesses search to tell and evaluate their decisions to approve novel remedies based on much less proof as considered with the FDA’s accelerated approval program. The Insights platform will offer sufferers with entry to an unparalleled well being news portal which can’t be matched through any different supply today.
From a international well being coverage standpoint, 80% of low to center sales countries don’t have the crucial guide to pressure most cancers coverage for determination making and useful useful source planning (IARC 2017). Insights permits stakeholders in rising markets with out the tools to conduct observational research or brands who don’t deem normal proof generation methods to be cost-effective in those localities, to nonetheless have entry to powerful RWE at enormously reduced costs and with out delay.
Lack of global health infrastructure today
resulting in substantial, wasted inefficiencies and least optimal health outcomes of key stakeholders; patient. In the current health sector, there is a lack of incentives for system health and service providers to focus on mutual collaboration and maximization patient outcome.
Vision Digipharms

to be a pioneer of value-based health delivery, innovative generation of evidence and patient empowerment in health
industry ‘using revolutionary blockchain technology.
Digipharm aims to leverage innovative blockchain technologies to address innovative patient access and cost barriers, reduce costs for all stakeholders, and bypass infrastructure limitations to drive value enhancements, provide innovative incentives and expeditions
transformation into a personalized health service.
With this project, we offer several solutions to solve health problems.
Solution
Solutions are more prominent in the Insights field
The Insights Platform will extract anonymous patient-level data from Reimburse platforms and health information systems to the world’s first RWE ‘live’ database. Insight will provide a symbiotic solution with Reimburse to complement the progressive transformation toward a value-based health delivery system.
Development of ‘live’ repository proof
will enable the integration of knowledge back into the delivery system in real time to facilitate decision-making, drug development and health-related research. Patients will be given incentives
to donate their health information to the Insight platform and will gain valuable access to health information that is currently unreachable.
Reimbursement Platform

utilizing the advantages of automated ‘smart contracting’ and blockchain technology; facilitate the adoption of a truly dynamic innovative pricing solution between the healthcare system and the manufacturer, in a safe and appropriate manner with minimal administrative burden. The use of the Reimbursement platform will accelerate the integration, coordination and delivery of patient centric health systems with a focus on improving patient outcomes while accelerating the ‘payment for value’ mechanism between payers and producers using
agreements that can be enforced neutrally in a peer way.
TOKEN DIGIPHARMS

Token Name: DPH
Total Supply: 100,000,000 Fixed (ERC-20)
Decimal: 18
Token Price 1.00 USD
Pre-Sales: 15,000,000
Main Sales: 50.000.000 DPH
Digipharms (DPH) Token will be used to fund licenses / access on the Digipharms platform. The fee is determined in the value of the USD price and the number of tokens required by the type of access to be made (producer, patient, payer or provider) combined in the form of each interaction. The quantity of the Token price remains subject to change, relative to the market value of the DPH.